These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

340 related articles for article (PubMed ID: 12653668)

  • 1. Target-based agents against ErbB receptors and their ligands: a novel approach to cancer treatment.
    Normanno N; Bianco C; De Luca A; Maiello MR; Salomon DS
    Endocr Relat Cancer; 2003 Mar; 10(1):1-21. PubMed ID: 12653668
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Anticancer therapy targeting the erbB family of receptor tyrosine kinases.
    Slichenmyer WJ; Fry DW
    Semin Oncol; 2001 Oct; 28(5 Suppl 16):67-79. PubMed ID: 11706398
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Radiotherapy and inhibitors of epidermal growth factor receptor: preclinical findings and preliminary clinical trials].
    Azria D; Larbouret C; Robert B; Culine S; Ychou M; Verrelle P; Dubois JB; Pèlegrin A
    Bull Cancer; 2003 Nov; 90 Spec No():S202-12. PubMed ID: 14763141
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Epidermal growth factor receptor tyrosine kinase inhibitors in late stage clinical trials.
    Ciardiello F; De Vita F; Orditura M; De Placido S; Tortora G
    Expert Opin Emerg Drugs; 2003 Nov; 8(2):501-14. PubMed ID: 14662002
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The EGF receptor family as targets for cancer therapy.
    Mendelsohn J; Baselga J
    Oncogene; 2000 Dec; 19(56):6550-65. PubMed ID: 11426640
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Gefitinib ('Iressa', ZD1839) and new epidermal growth factor receptor inhibitors.
    Blackledge G; Averbuch S
    Br J Cancer; 2004 Feb; 90(3):566-72. PubMed ID: 14760365
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Rationale and clinical validation of epidermal growth factor receptor as a target in the treatment of head and neck cancer.
    Caponigro F
    Anticancer Drugs; 2004 Apr; 15(4):311-20. PubMed ID: 15057134
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Epithelial growth factor receptor interacting agents.
    Baselga J; Albanell J
    Hematol Oncol Clin North Am; 2002 Oct; 16(5):1041-63. PubMed ID: 12512382
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The ErbB/HER family of protein-tyrosine kinases and cancer.
    Roskoski R
    Pharmacol Res; 2014 Jan; 79():34-74. PubMed ID: 24269963
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Epidermal growth factor receptor inhibitors: a new prospective in the treatment of lung cancer.
    Tiseo M; Loprevite M; Ardizzoni A
    Curr Med Chem Anticancer Agents; 2004 Mar; 4(2):139-48. PubMed ID: 15032719
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The ErbB receptor family: a therapeutic target for cancer.
    de Bono JS; Rowinsky EK
    Trends Mol Med; 2002; 8(4 Suppl):S19-26. PubMed ID: 11927283
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Growth factors and their receptors: new targets for prostate cancer therapy.
    Barton J; Blackledge G; Wakeling A
    Urology; 2001 Aug; 58(2 Suppl 1):114-22. PubMed ID: 11502465
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Targeting ErbB receptors in breast cancer].
    Fumoleau P; Campone M; Coudert B; Mayer F; Favier L; Ferrant E
    Bull Cancer; 2007; 94(7 Suppl):F147-70. PubMed ID: 17964992
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Epidermal growth factor receptor as a target for chemotherapy.
    Vallbohmer D; Lenz HJ
    Clin Colorectal Cancer; 2005 Apr; 5 Suppl 1():S19-27. PubMed ID: 15871762
    [TBL] [Abstract][Full Text] [Related]  

  • 15. HER1/EGFR targeting: refining the strategy.
    Pérez-Soler R
    Oncologist; 2004; 9(1):58-67. PubMed ID: 14755015
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Epidermal growth factor receptor (EGFR) inhibitors in cancer therapy.
    Ciardiello F; De Vita F
    Prog Drug Res; 2005; 63():93-114. PubMed ID: 16265878
    [No Abstract]   [Full Text] [Related]  

  • 17. [Molecular target-based cancer therapy: epidermal growth factor receptor inhibitors].
    Tamura T
    Nihon Geka Gakkai Zasshi; 2002 Feb; 103(2):233-6. PubMed ID: 11904986
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Epidermal growth factor receptor as a therapeutic target in colorectal cancer.
    Cohen RB
    Clin Colorectal Cancer; 2003 Feb; 2(4):246-51. PubMed ID: 12620146
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cetuximab: an epidermal growth factor receptor chemeric human-murine monoclonal antibody.
    Harding J; Burtness B
    Drugs Today (Barc); 2005 Feb; 41(2):107-27. PubMed ID: 15821783
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Why the epidermal growth factor receptor? The rationale for cancer therapy.
    Baselga J
    Oncologist; 2002; 7 Suppl 4():2-8. PubMed ID: 12202782
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.